Cargando…
A case of simultaneous occurrence of hepatitis and pancreatitis during the combination immunochemotherapy for non-small cell lung carcinoma
Immune checkpoint inhibitors (ICIs) improved the prognosis of patients with advanced lung cancers. The combination therapy of cytotoxic drugs and ICI is approved as first-line chemotherapy in non-small-cell lung cancer (NSCLC) and extensive disease small-cell lung cancer (ED-SCLC). It has been repor...
Autores principales: | Tanaka, Satoshi, Asakawa, Ryo, Komuta, Kiyohide, Tanizaki, Satoshi, Kanai, Tomohiro, Kuroyama, Muneyoshi, Shimazu, Kohki, Uchida, Junji, Yakushijin, Takayuki, Ueno, Kiyonobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589533/ https://www.ncbi.nlm.nih.gov/pubmed/33134073 http://dx.doi.org/10.1016/j.rmcr.2020.101266 |
Ejemplares similares
-
A case of CD74‐ROS1‐positive lung adenocarcinoma diagnosed by next‐generation sequencing achieved long‐term survival with pemetrexed regimens
por: Tanaka, Satoshi, et al.
Publicado: (2023) -
Bilateral refractory pneumothorax treated by pleurodesis and bronchial occlusion in a COVID‐19 patient
por: Tanaka, Satoshi, et al.
Publicado: (2022) -
Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study
por: Matsumoto, Kinnosuke, et al.
Publicado: (2021) -
Current trends of anticancer immunochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013) -
Severe Post-COVID-19 Organizing Pneumonia during Cancer Immunochemotherapy
por: Kitahara, Asako, et al.
Publicado: (2022)